ABCB1 and colorectal cancer: These data suggested that ABCB1 gene knockout using the CRISPR/Cas9 system was effective in restoring the intracellular level and decrease the efflux of ABCB1 substrate [3H]‐paclitaxel in ABCB1 overexpressing MDR colorectal cancer cells.